Jean-Claude Provost

Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Part of Thermo Fisher Scientific, Inc., IoDP Medical Imaging Research provides customized services for medical image analysis and image management in clinical trials to pharmaceutical and biotech companies, CROs, and public research organizations. The company is based in Sevres, France. IoDP Medical Imaging Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 27, 2004.

Part of Thermo Fisher Scientific, Inc., Center For Clinical & Basic Research is a Danish company that provides radiology services. The company is based in Ballerup, Denmark. The company was founded by Claus Henrik Christiansen. Center For Clinical & Basic Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 14, 2006.

Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.